Corcept Reports Q3 Revenue of $340.5 Million
Q3 2026 revenue was $340.5 million, compared with $256.1 million in Q2. Net income was $126.8 million versus $43.0 million. The company reiterated 2026 revenue guidance of $1.1 billion to $1.2 billion.
Story updates
09:09:45 PM UTC
SquawkNews
Nov 03 (Reuters) - Corcept Therapeutics Q3 revenue USD 340.472 million vs. IBES estimate USD 336.4 million.
09:09:53 PM UTC
SquawkNews
CORCEPT THERAPEUTICS Q3 REVENUE USD 340.472 MILLION VS. IBES ESTIMATE USD 336.4 MILLION
Q3 2026 revenue was $340.5M versus $256.1M in Q2, and net income was $126.8M versus $43.0M. Corcept reiterated 2026 revenue guidance of $1.1B—$1.2B.Material DetailsContext by AI AnalystThis is a quarterly results update showing sequential revenue and net income growth alongside continued expansion…